{"meta":{"humanUrl":"https://fr.bookimed.com/clinics/country=germany/procedure=car-t-cell-therapy/best/","canonicalUrl":"https://fr.bookimed.com/clinics/country=germany/procedure=car-t-cell-therapy/best/","jsonUrl":"https://fr.bookimed.com/clinics/country=germany/procedure=car-t-cell-therapy/best/data.json","title":"Best clinics for Thérapie CAR T in Allemagne — Ratings & Reviews | Bookimed","description":"2 top-rated clinics for Thérapie CAR T in Allemagne. Compare rankings, prices, and patient reviews on Bookimed.","heading":"Best clinics for Thérapie CAR T in Allemagne","locale":"fr","schemaVersion":"ClinicBestPageDataV1","snapshotId":"164c8f46-b8aa747e","contentVersion":"164c8f46","generatedAt":"2026-11-16T03:35:56.840Z"},"filters":{"country":"germany","procedure":"car-t-cell-therapy","page":1},"pagination":{"page":1,"totalCount":2,"totalPages":1},"breadcrumbs":[{"name":"Home","url":"/"},{"name":"Clinics","url":"/clinics/"},{"name":"Allemagne","url":"/clinics/country=germany/"},{"name":"Thérapie CAR T","url":"/clinics/country=germany/procedure=car-t-cell-therapy/"},{"name":"Best","url":"/clinics/country=germany/procedure=car-t-cell-therapy/best/"}],"entities":[{"name":"Allemagne","alias":"germany","type":"country","id":22},{"name":"Thérapie CAR T","alias":"car-t-cell-therapy","type":"procedure","id":800}],"clinics":{"clinics":[{"text":"<p>La clinique Nordwest – l'un des 22 centres d'oncologie certifiés par l'ESMO dans le monde – propose la thérapie par cellules CAR-T sous la direction du professeur Elke Jäger, une oncologue allemande de premier plan figurant parmi les meilleurs médecins du magazine Focus. Les consultations à distance coûtent environ 1 160 € et comprennent généralement une consultation vidéo, l'examen des examens antérieurs et un avis radio-oncologique. La clinique élabore un programme individuel de thérapie par cellules CAR-T après avoir évalué l'éligibilité du patient.</p>","text_type":"mt_wow_description","best_texts":{"techniques":"Thérapie par cellules CAR-T","good_fit_for":"Programmes de thérapie par cellules CAR-T individualisés","why_its_ranked":"Cet établissement propose des programmes personnalisés de thérapie par cellules CAR-T incluant des consultations préparatoires approfondies. Ce centre d'oncologie certifié par l'ESMO figure parmi les meilleurs hôpitaux allemands pour l'efficacité du traitement du cancer."},"agency_settings":[{"setting_name":"is_new","setting_value":"0"},{"setting_name":"kids_only","setting_value":"0"}],"procedure_prices":[{"prices":{"price_from":500,"price_to":1300,"currency":"USD","id":13544},"diagnostic":{"id":296,"name":"Scanner d'une partie du corps","alias":"ct-scan-of-the-body-part"}},{"prices":{"price_from":337,"price_to":337,"currency":"USD","id":12559},"diagnostic":{"id":84,"name":"Analyse approfondie du sang","alias":"extended-analysis-of-blood"}}],"reviews":[],"clinic":{"id":136,"alias":"clinic-nordwest","name":"Nordwest Clinic (Krankenhaus)","short_description":"<p>La clinique Nordwest est un hôpital allemand à l'origine d'innovations telles que l'échographie 3D et les vaccins anticancéreux. Ses principales spécialités sont l'oncologie, l'orthopédie, la cardiologie, la neurologie, la gynécologie, l'urologie et la chirurgie. Nommé meilleur hôpital allemand par Focus et parmi les meilleurs hôpitaux du monde par Newsweek.</p> <ul> <li>Le centre d'oncologie et d'hématologie est certifié ESMO – seules 22 cliniques dans le monde détiennent ce statut.</li> <li>Seul centre certifié de la région pour les ultrasons focalisés (FUS), reconnus par le magazine Time comme une invention majeure.</li> <li>Comprend 5 instituts de recherche, 11 cliniques spécialisées et 17 centres certifiés.</li> <li>Traite plus de 60 000 patients par an avec 286 médecins répartis dans 28 départements.</li> <li>Chambres individuelles avec WiFi, TV et repas. Services de traduction fournis pour les patients internationaux.</li> </ul>","images":[{"base_url":"clinic/5c87d1969700b","title":"Bâtiment de la clinique Nordwest à Francfort, Allemagne"},{"base_url":"clinic/5ac32d5931619","title":"Couloir hospitalier à Nordwest Clinic Francfort avec équipement médical moderne"},{"base_url":"clinic/5ac32d5f7cbdc","title":"Salle de radiothérapie à la clinique Nordwest avec patient et personnel médical"},{"base_url":"clinic/5ac32d5a4925b","title":"Unité de soins intensifs à la clinique Nordwest avec personnel médical et équipements"}],"flags":[{"name":"is_hide","value":false},{"name":"has_active_agencies","value":false}],"geo":{"country":{"name":"Allemagne","id":22,"alias":"germany","iso_code":"DE"},"city":{"name":"Francfort-sur-le-Main","id":354,"alias":"frankfurt-am-main"},"address":"Steinbacher Hohl 2-26, 60488 Frankfurt am Main, Germany"},"rating":{"rating":4.5,"google":4,"percent_of_satisfied_clients":91},"statistics":{"number_of_reviews":57,"doctors_number":286,"year_foundation":1963},"accreditations":[{"logo":"https://s3.eu-central-1.amazonaws.com/bookimed/accreditations/5ceb72be5c3ae.jpeg","name":"Certificat de Recherche et d'Investissement de l'Entreprise TÜV AG","country_code":"DE"},{"logo":"https://s3.eu-central-1.amazonaws.com/bookimed/accreditations/5ceb72d2c6a2f.jpeg","name":"Meilleur hôpital allemand selon le classement Focus 2019","country_code":"DE"},{"logo":"https://s3.eu-central-1.amazonaws.com/bookimed/accreditations/609cdeda74941.jpeg","name":"Meilleurs hôpitaux du monde 2021 par Newsweek","country_code":"US"}],"agency_settings":[{"setting_name":"is_new","setting_value":"0"},{"setting_name":"kids_only","setting_value":"0"}]}},{"text":"<p style=\"text-align:justify;\">\n\t spécialisé en chirurgie esthétique et plastique est situé à Nuremberg. Le centre a été ouvert en 2002 par le Dr. Radu sur la base de l'hôpital de St. Theresa.<br />\n\t </p> <p>\n</p>","text_type":"short_description","agency_settings":[{"setting_name":"is_new","setting_value":"0"},{"setting_name":"kids_only","setting_value":"0"}],"reviews":[],"clinic":{"id":241,"alias":"dr-radu--partner-aesthetic-and-plastic-surgery---nuremberg","name":" Dr. Radu + Partner Aesthetic and Plastic Surgery - Nuremberg","short_description":"<p style=\"text-align:justify;\">\n\t spécialisé en chirurgie esthétique et plastique est situé à Nuremberg. Le centre a été ouvert en 2002 par le Dr. Radu sur la base de l'hôpital de St. Theresa.<br />\n\t </p> <p>\n</p>","images":[{"base_url":"clinic/5ab24b3252209","title":"Façade moderne de la clinique Dr. Radu + Partner Aesthetic and Plastic Surgery à Nuremberg"},{"base_url":"clinic/5ab24b32a3840","title":"Couloir de la clinique Dr. Radu + Partner Aesthetic and Plastic Surgery, Nuremberg"},{"base_url":"clinic/5ab24b32d7e03","title":"Personnel médical chez Dr. Radu + Partner Aesthetic and Plastic Surgery, Nuremberg"},{"base_url":"clinic/5ab24b332f9b3","title":"Salle de soins chez Dr. Radu + Partner Aesthetic and Plastic Surgery, Nuremberg"}],"flags":[{"name":"is_hide","value":false},{"name":"has_active_agencies","value":false}],"geo":{"country":{"name":"Allemagne","id":22,"alias":"germany","iso_code":"DE"},"city":{"name":"Nuremberg","id":332,"alias":"nuernberg"},"address":"Am Tullnaupark 8, 90402 Nürnberg, Germany"},"rating":{"rating":0,"google":4.3,"percent_of_satisfied_clients":0},"statistics":{"number_of_reviews":0,"doctors_number":2,"year_foundation":2002},"accreditations":[],"agency_settings":[{"setting_name":"is_new","setting_value":"0"},{"setting_name":"kids_only","setting_value":"0"}]}}],"meta":{"total_count":2,"total_pages":1}},"clinicsMeta":{"total_count":2,"total_pages":1},"clinicsCount":2,"clinicsCountByEntity":{"clinic_count":29},"doctors":{"doctors":[],"meta":{"total_count":0,"total_pages":1}},"offers":{"cards":[],"metadata":{"total_count":0}},"listingTexts":{"entity_texts":{},"texts":{}},"relations":{"countries":[{"name":"Allemagne","alias":"germany","iso_code":"DE"},{"name":"Autriche","alias":"austria","iso_code":"AT"},{"name":"Chine","alias":"china","iso_code":"CN"},{"name":"Espagne","alias":"spain","iso_code":"ES"},{"name":"Israël","alias":"israel","iso_code":"IL"},{"name":"Italie","alias":"italy","iso_code":"IT"},{"name":"Lituanie","alias":"lithuania","iso_code":"LT"},{"name":"Royaume-Uni","alias":"united-kingdom","iso_code":"GB"},{"name":"République de Corée","alias":"republic-of-korea","iso_code":"KR"},{"name":"Turquie","alias":"turkey","iso_code":"TR"},{"name":"États-Unis","alias":"united-states","iso_code":"US"}],"cities":[{"name":"Nuremberg","alias":"nuernberg"},{"name":"Francfort-sur-le-Main","alias":"frankfurt-am-main"}],"operations":[{"name":"Chimiothérapie","alias":"chemotherapy"},{"name":"Thérapie CAR T","alias":"car-t-cell-therapy"},{"name":"Chimiothérapie contre la leucémie","alias":"leukemia-chemotherapy"},{"name":"Chimiothérapie du lymphome","alias":"lymphoma-chemotherapy"}],"diagnostics":[{"name":"Ultrason","alias":"u.s."},{"name":"Numération globulaire complète","alias":"total-blood"},{"name":"Analyse approfondie du sang","alias":"extended-analysis-of-blood"},{"name":"IRM d’une zone","alias":"mri-one-department"},{"name":"Biopsie de moelle osseuse","alias":"lumbar-puncture-bone-marrow"},{"name":"Biopsie","alias":"biopsy"},{"name":"Coagulogramme","alias":"coagulogram"},{"name":"Test sanguin avec marqueur tumoral","alias":"identification-of-tumor-markers"},{"name":"CT (tomodensitométrie)","alias":"ct"},{"name":"Consultation avec un hématologue","alias":"consultation-hematologist"},{"name":"Diagnostic oncologique complexe","alias":"somplex-oncology-diagnostic"},{"name":"Trépanobiopsie","alias":"core-needle-biopsy"},{"name":"Etude cytogénétique de la moelle osseuse","alias":"cytogenetic-study-of-the-bone-marrow"},{"name":"Scanner d'une partie du corps","alias":"ct-scan-of-the-body-part"},{"name":"Ponction médullaire avec analyse cytogénétique","alias":"bone-marrow-puncture-with-cytogenetic-analysis"},{"name":"Révision des résultats IRM","alias":"revision-of-mri-results"},{"name":"IRM cérébrale","alias":"brain-mri"},{"name":"Consultation avec élaboration du plan de traitement","alias":"consultation-with-creation-of-treatment-plan"},{"name":"TEP/TDM dans le lymphome","alias":"petct-in-lymphoma"},{"name":"Immunohistochimie","alias":"immunohistochemistry"},{"name":"TDM des sinus paranasaux","alias":"ct-of-the-paranasal-sinuses"},{"name":"Prise de sang pour lymphome","alias":"lymphoma-blood-test"},{"name":"Diagnostic complet de la leucémie","alias":"somprehensive-diagnosis-of-leukemia"}],"illnesses":[{"name":"Lymphome","alias":"lymphoma"},{"name":"Lymphome de Hodgkin","alias":"hodgkin-s-disease"},{"name":"Myélome","alias":"myeloma"},{"name":"Lymphome non hodgkinien","alias":"non-hodgkin-s-lymphoma"},{"name":"Lymphome folliculaire","alias":"follicular-lymphoma"},{"name":"Lymphome de Burkitt","alias":"burkitt-s-lymphoma"}],"illnessKinds":[{"name":"Hématologie Oncologie","alias":"hematology"}],"illness_kinds":[{"name":"Hématologie Oncologie","alias":"hematology"}]},"popularSearches":[{"name":"Chimiothérapie","alias":"chemotherapy","type":"operation","id":37},{"name":"Une greffe de moelle osseuse","alias":"bone-marrow-transplantation","type":"operation","id":141},{"name":"Plasmaphérèse","alias":"plasmapheresis","type":"operation","id":386},{"name":"Thérapie CAR T","alias":"car-t-cell-therapy","type":"operation","id":800},{"name":"Thérapie biologique","alias":"biological-therapy","type":"operation","id":154},{"name":"Ultrason","alias":"u.s.","type":"diagnostic","id":37},{"name":"IRM d’une zone","alias":"mri-one-department","type":"diagnostic","id":6},{"name":"Consultation avec élaboration du plan de traitement","alias":"consultation-with-creation-of-treatment-plan","type":"diagnostic","id":457},{"name":"CT (tomodensitométrie)","alias":"ct","type":"diagnostic","id":96},{"name":"Numération globulaire complète","alias":"total-blood","type":"diagnostic","id":83},{"name":"Leucémie","alias":"leukemia","type":"illness","id":393},{"name":"Lymphome","alias":"lymphoma","type":"illness","id":12},{"name":"Anémie aplastique","alias":"aplastic-anemia","type":"illness","id":319},{"name":"Myélome","alias":"myeloma","type":"illness","id":126},{"name":"Leucémie lymphoblastique aiguë","alias":"acute-lymphoblastic-leukemia","type":"illness","id":492}],"operationPrices":{"operation_prices":{"800":{"operation":{"name":"Thérapie CAR T","alias":"car-t-cell-therapy","use_for_listing":true},"country_price":{"US":{"amount":420000,"max_amount":540000,"currency":"USD","clinic_count":0,"price_kind":"estimate","price_source":"parsed","scope":"country"},"TR":{"amount":150000,"max_amount":220000,"currency":"USD","clinic_count":3,"price_kind":"from_range","price_source":"mixed","scope":"country"},"DE":{"amount":285000,"max_amount":365000,"currency":"USD","clinic_count":0,"price_kind":"estimate","price_source":"parsed","scope":"country"},"TH":{"amount":150000,"max_amount":220000,"currency":"USD","clinic_count":0,"price_kind":"estimate","price_source":"parsed","scope":"country"},"ES":{"amount":380000,"max_amount":520000,"currency":"USD","clinic_count":2,"price_kind":"from_range","price_source":"tariff","scope":"country"}},"available_clinics":{"UA":false,"FR":false,"GB":false,"US":false,"IL":true,"TR":true,"MX":false,"DE":false,"CA":false,"AE":false,"TH":false,"PL":false,"KR":false,"CZ":false,"AT":false,"ES":true,"IT":true,"CN":true,"AU":false,"IN":false,"MY":false,"VN":false,"BR":false}},"1699":{"operation":{"name":"Thérapie CAR-T pour le DLBCL","alias":"car-t-for-dlbcl","use_for_listing":false},"country_price":{"US":{"amount":420000,"max_amount":530000,"currency":"USD","clinic_count":0,"price_kind":"estimate","price_source":"parsed","scope":"country"},"TR":{"amount":140000,"max_amount":190000,"currency":"USD","clinic_count":0,"price_kind":"estimate","price_source":"parsed","scope":"country"},"DE":{"amount":285000,"max_amount":355000,"currency":"USD","clinic_count":0,"price_kind":"estimate","price_source":"parsed","scope":"country"},"TH":{"amount":185000,"max_amount":250000,"currency":"USD","clinic_count":0,"price_kind":"estimate","price_source":"parsed","scope":"country"},"ES":{"amount":185000,"max_amount":255000,"currency":"USD","clinic_count":0,"price_kind":"estimate","price_source":"parsed","scope":"country"}},"available_clinics":{"US":false,"TR":false,"DE":false,"TH":false,"ES":false}},"1700":{"operation":{"name":"Thérapie CAR-T pour le myélome multiple","alias":"car-t-for-multiple-myeloma","use_for_listing":false},"country_price":{"US":{"amount":420000,"max_amount":540000,"currency":"USD","clinic_count":0,"price_kind":"estimate","price_source":"parsed","scope":"country"},"TR":{"amount":140000,"max_amount":190000,"currency":"USD","clinic_count":0,"price_kind":"estimate","price_source":"parsed","scope":"country"},"DE":{"amount":340000,"max_amount":430000,"currency":"USD","clinic_count":0,"price_kind":"estimate","price_source":"parsed","scope":"country"},"TH":{"amount":200000,"max_amount":280000,"currency":"USD","clinic_count":0,"price_kind":"estimate","price_source":"parsed","scope":"country"},"ES":{"amount":185000,"max_amount":240000,"currency":"USD","clinic_count":0,"price_kind":"estimate","price_source":"parsed","scope":"country"}},"available_clinics":{"US":false,"TR":false,"DE":false,"TH":false,"ES":false}},"1702":{"operation":{"name":"Thérapie CAR-T pour la LAL pédiatrique","alias":"car-t-for-pediatric-all","use_for_listing":false},"country_price":{"US":{"amount":475000,"max_amount":650000,"currency":"USD","clinic_count":0,"price_kind":"estimate","price_source":"parsed","scope":"country"},"TR":{"amount":140000,"max_amount":220000,"currency":"USD","clinic_count":0,"price_kind":"estimate","price_source":"parsed","scope":"country"},"DE":{"amount":290000,"max_amount":400000,"currency":"USD","clinic_count":0,"price_kind":"estimate","price_source":"parsed","scope":"country"},"TH":{"amount":200000,"max_amount":280000,"currency":"USD","clinic_count":0,"price_kind":"estimate","price_source":"parsed","scope":"country"},"ES":{"amount":240000,"max_amount":340000,"currency":"USD","clinic_count":0,"price_kind":"estimate","price_source":"parsed","scope":"country"}},"available_clinics":{"US":false,"TR":false,"DE":false,"TH":false,"ES":false}}}},"operationIndicators":{"details":{"anesthesia":"general","days_in_clinic":7,"days_in_country":14,"rehabilitation_days":30,"satisfied_percent":78,"treatment_duration_hours":4},"illness_kind_details":{"requests_processed":6882}},"direction":{"id":20,"name":"Hématologie Oncologie","alias":"hematology"},"illness_kind":{"id":20,"name":{"en":"Hematology Oncology"}},"parsed_details":{"procedure_type":"therapy","fields":{"anesthesia":["none"],"back_to_work_days":{"min":60,"max":90,"unit":"days","qualifier":"Desk work usually resumes at 2–3 months, once CRS/ICANS risk and cytopenias settle. Later if fatigue, neurotoxicity or infections persist."},"complication_rate_pct":{"min":50,"max":95,"unit":"percent","qualifier":"Any-grade cytokine release syndrome or neurotoxicity within about 8 weeks; severe grade 3+ events roughly 10-25%."},"contraindications":["Active uncontrolled infection, including uncontrolled hepatitis B/C or HIV","Significant cardiac, pulmonary, renal or hepatic dysfunction","Active CNS or autoimmune neurological disease (relative, product-dependent)","Poor performance status or rapid progression during manufacturing (relative)","Severe hypersensitivity to DMSO or product excipients","Pregnancy or breastfeeding","Active uncontrolled graft-versus-host disease (relative, prior transplant)"],"days_in_clinic":{"min":10,"max":21,"unit":"nights","qualifier":"Inpatient stay with daily CRS/ICANS monitoring, about 2 weeks; longer if ICU needed."},"diagnostic_duration_minutes":null,"diagnostic_preparation":null,"diagnostic_referral_needed":null,"diagnostic_result_time_hours":null,"exercise_resume_weeks":{"min":8,"max":12,"unit":"weeks","qualifier":"Strenuous exercise waits about 2–3 months, until counts recover and early neurotoxicity and infection risk passes. Light walking earlier."},"final_result_months":{"min":1,"max":3,"unit":"months","qualifier":"Response is assessed at about 1 month and 3 months after infusion; remission durability needs longer follow-up."},"fly_home_after_days":{"min":28,"max":42,"unit":"days","qualifier":"Stay near the centre at least 4 weeks, past peak CRS/ICANS risk. Fly if no toxicity, counts acceptable."},"follow_up_visits":[{"purpose":"assessment","requirement":"routine","after":{"min":7,"max":14,"unit":"days","qualifier":"Frequent early monitoring for cytokine release syndrome and neurotoxicity if discharged"}},{"purpose":"result_review","requirement":"routine","after":{"min":28,"max":35,"unit":"days","qualifier":"First response assessment, about day 28-35 after infusion"}},{"purpose":"result_review","requirement":"routine","after":{"min":85,"max":100,"unit":"days","qualifier":"Response reassessment about day 85-100 (around 3 months) after infusion"}}],"indications":["Relapsed or refractory large B-cell lymphoma","Relapsed or refractory B-cell acute lymphoblastic leukemia","Relapsed or refractory follicular and mantle cell lymphoma","Relapsed or refractory multiple myeloma (BCMA-directed)","Relapsed or refractory chronic lymphocytic leukemia"],"main_risks":["Cytokine release syndrome","Immune effector cell-associated neurotoxicity syndrome","Prolonged cytopenias","Infections and hypogammaglobulinemia","B-cell aplasia","Hemophagocytic lymphohistiocytic-like syndrome","Secondary T-cell malignancies (rare)","Tumor lysis syndrome","Infusion-related hypersensitivity reactions"],"pain":"The infusion itself is generally painless; fever, headache, body aches and malaise may occur with cytokine release, and leukapheresis involves line placement with mild discomfort.","preparation":["Specialist eligibility assessment and disease staging","Infection screening and organ function evaluation","Leukapheresis to collect the patient's T cells","Possible bridging therapy while the cells are manufactured (weeks)","Lymphodepleting chemotherapy a few days before infusion","Central venous access as needed","Arrange nearby accommodation and a caregiver after infusion","Confirm target antigen (e.g., CD19, BCMA) and prior-therapy eligibility","Pre-infusion premedication (paracetamol and antihistamine)","Access to tocilizumab and ICU-level support before infusion"],"recovery_timeline":[{"phase":"Infusion and first 1-2 weeks","description":"Single IV infusion followed by close monitoring for cytokine release syndrome and neurotoxicity, usually peaking in the first 1-2 weeks.","restrictions":["Stay near the treatment center"]},{"phase":"Weeks 2-4","description":"Discharge when stable, frequent visits, blood count and infection monitoring, first response assessment around day 28.","restrictions":["Stay near the treatment center until about day 28","No driving for at least 8 weeks","Avoid crowds and infection exposure"]},{"phase":"Months 2-12","description":"Gradual recovery of blood counts and energy, immune function monitoring, immunoglobulin replacement if needed, response reassessment.","restrictions":["Delay live vaccines per specialist advice"]}],"rehabilitation_days":{"min":60,"max":90,"unit":"days","qualifier":"Functional recovery after the 4-week monitoring period; slower with persistent fatigue, cytopenias, neurotoxicity or infections."},"result_longevity":"In large B-cell lymphoma, about 40% remain progression-free at 1 year; some stay in long-term remission. In B-ALL, about 36% relapse; CAR T cells can persist up to about 5 years.","revision_rate_pct":null,"scars":"There is no surgical incision, only small puncture marks from the leukapheresis or central venous line sites.","sessions_or_stages":{"sessions":{"min":1,"max":1,"unit":"visits","qualifier":"One CAR T-cell infusion; leukapheresis and lymphodepletion are preceding stages."},"stages":[{"code":"leukapheresis","label":"Leukapheresis to collect T cells","after":{"min":0,"max":0,"unit":"days","qualifier":"Starting point of the treatment pathway"}},{"code":"lymphodepletion","label":"Lymphodepleting chemotherapy","after":{"min":23,"max":58,"unit":"days","qualifier":"About 3-8 weeks after leukapheresis; 2-5 days before infusion"}},{"code":"car_t_infusion","label":"CAR T-cell infusion","after":{"min":28,"max":63,"unit":"days","qualifier":"Depends on manufacturing and product release time"}}],"qualifier":"Single-infusion therapy; timelines vary by product and center."},"success":{"metric":"Complete response rate in relapsed/refractory large B-cell lymphoma (3rd-line or later)","value":51,"unit":"percent","horizon":"Best response, typically assessed at 1-3 months after infusion","evidence_status":"limited","population":"Adults with relapsed/refractory LBCL after two or more prior lines"},"techniques":[{"name":"Autologous CD19-directed CAR T-cell therapy","suits_whom":"Relapsed/refractory B-cell lymphomas and B-ALL","recovery":"Inpatient monitoring about 10-21 days, then nearby follow-up to day 28."},{"name":"Autologous BCMA-directed CAR T-cell therapy","suits_whom":"Relapsed/refractory multiple myeloma after multiple prior lines","recovery":"Similar monitoring; prolonged cytopenias are common."}],"treatment_conditions":["inpatient"],"treatment_duration_hours":{"min":0.5,"max":1,"unit":"hours","qualifier":"Duration of the single CAR T-cell infusion itself; leukapheresis (about 3-6 hours) and lymphodepletion are separate."},"initial_assessment_documents":["Pathology report with CD19 or BCMA status","Summary of prior treatment lines and responses","Recent PET-CT or MRI report","Bone marrow biopsy report","Recent CBC, kidney and liver function tests","Echocardiogram report (if available)"],"travel_trips":{"min":1,"max":2,"one_trip_possible":true,"qualifier":"Cell collection, then 3-9 weeks manufacturing, usually at home; return for infusion and 4+ weeks nearby. One trip means staying."},"clinic_checks":{"status":"ok","items":[{"id":"C1","text":"Ask the clinic for examples of the practitioners' experience with the exact procedure you are planning","scope":"treatment_abroad","source":{"url":"https://travelaware.campaign.gov.uk/surgery-abroad-cut-out-the-risk/","host":"travelaware.campaign.gov.uk","quote":"Ask for examples of the practitioners’ experience with the surgery you are intending to have.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"C2","text":"Ask whether a doctor is always present in the clinic and whether a high dependency or intensive care unit exists","scope":"treatment_abroad","source":{"url":"https://www.bapras.org.uk/public/patient-information/cosmetic-surgery/cosmetic-surgery-abroad","host":"bapras.org.uk","quote":"Is there always a doctor in the clinic and is there a high dependency or intensive care unit?","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"C3","text":"Confirm the surgeon is trained and experienced in the exact procedure you are considering, not just in surgery generally","scope":"treatment_abroad","source":{"url":"https://www.isaps.org/discover/patients-home/considering-your-procedure-abroad/finding-a-surgeon-abroad/","host":"isaps.org","quote":"Verify that the surgeon is trained and experienced in performing the procedure you are considering.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"C4","text":"Check that the surgeon who consults with you is the same person who will carry out the procedure","scope":"treatment_abroad","source":{"url":"https://travelaware.campaign.gov.uk/surgery-abroad-cut-out-the-risk/","host":"travelaware.campaign.gov.uk","quote":"Check that the surgeon you consult with, will be the same person carrying out the procedure.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"C5","text":"Decide before you travel where check-ups after the operation will take place, because follow-up abroad may be missing or weaker","scope":"treatment_abroad","source":{"url":"https://www.nhs.uk/conditions/cosmetic-procedures/cosmetic-surgery-abroad/","host":"nhs.uk","quote":"You need to think about where check-ups will take place.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"red_flags":{"status":"ok","items":[{"id":"F1","text":"Pressure to decide quickly, or cheap time-limited offers, is a warning sign of a clinic offer","scope":"treatment_abroad","source":{"url":"https://travelaware.campaign.gov.uk/surgery-abroad-cut-out-the-risk/","host":"travelaware.campaign.gov.uk","quote":"Don’t be pressured into quick decisions either through forceful persuasion or cheap, time limited offers.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"F2","text":"An advert or information that guarantees complete success should raise concerns","scope":"treatment_abroad","source":{"url":"https://travelaware.campaign.gov.uk/surgery-abroad-cut-out-the-risk/","host":"travelaware.campaign.gov.uk","quote":"Any advert or information that guarantees complete success should raise concerns.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"F3","text":"Forceful persuasion or cheap, time-limited offers pushing you into a quick decision","scope":"treatment_abroad","source":{"url":"https://travelaware.campaign.gov.uk/surgery-abroad-cut-out-the-risk/","host":"travelaware.campaign.gov.uk","quote":"Don’t be pressured into quick decisions either through forceful persuasion or cheap, time limited offers.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"warning_signs":{"status":"ok","items":[{"id":"W1","text":"Confusion or difficulty communicating","urgency":"emergency","general":false,"source":{"url":"https://www.cancer.gov/news-events/cancer-currents-blog/2019/cancer-immunotherapy-investigating-side-effects","host":"cancer.gov","quote":"Patients also may experience neurologic symptoms such as confusion, tremors, or difficulty communicating.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"W2","text":"Excessive sleepiness","urgency":"contact_clinic","general":false,"source":{"url":"https://www.cancer.gov/about-cancer/treatment/research/car-t-cells","host":"cancer.gov","quote":"Some of the hallmark signs of ICANS include confusion, excessive sleepiness, and impaired speech.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"W3","text":"Trouble breathing","urgency":"emergency","general":false,"source":{"url":"https://www.cancer.gov/about-cancer/treatment/side-effects/flu-symptoms","host":"cancer.gov","quote":"Immunotherapy treatments such as CAR T-cell therapy and some monoclonal antibodies may cause cytokine release syndrome (CRS), a condition that can lead to severe flu-like symptoms as well as a rash, rapid heartbeat, low blood pressure, and trouble breathing.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"W4","text":"Fever","urgency":"contact_clinic","general":true,"source":{"url":"https://www.cancer.gov/news-events/cancer-currents-blog/2019/cancer-immunotherapy-investigating-side-effects","host":"cancer.gov","quote":"Many patients who receive CAR T-cell therapy develop a condition known as cytokine release syndrome, which can cause a fever, fast heart rate, low blood pressure, and rash, among other symptoms.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"take_home":{"status":"ok","items":[{"id":"T1","text":"Shows emergency staff and other doctors the patient is a CAR T recipient","document":"car t wallet card","source":{"url":"https://www.mskcc.org/cancer-care/patient-education/car-cell-therapy-guide-adult-patients-caregivers","host":"mskcc.org","quote":"Carry your wallet card with you at all times.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"T2","text":"Home doctor needs the plan the treating team set for leaving hospital","document":"written discharge instructions","source":{"url":"https://www.mskcc.org/cancer-care/patient-education/car-cell-therapy-guide-adult-patients-caregivers","host":"mskcc.org","quote":"Your CAR T team will give you discharge instructions before you leave the hospital.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"T3","text":"Home doctor needs the exact medicines to continue treatment safely","document":"discharge medicines list","source":{"url":"https://www.cuh.nhs.uk/patient-information/discharge-advice-from-ward-c10c9-following-car-t-cell-therapy/","host":"cuh.nhs.uk","quote":"You will be given a copy of all the medications that you should take after being discharged.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"alternatives":{"status":"ok","items":[{"id":"A1","text":"You are older and not eligible for CAR T-cell therapy","name":"Bispecific antibody therapy","source":{"url":"https://www.cancer.gov/news-events/cancer-currents-blog/2022/tecvayli-multiple-myeloma","host":"cancer.gov","quote":"with bispecific antibodies you'll be able to treat older patients who are not eligible for CAR T-cell therapies","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200},"operation_id":null}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"technique_details":{"status":"ok","items":[{"id":"autologous-cd19-directed-car","name":"Autologous CD19-directed CAR T-cell therapy","how_it_works":{"text":"Modified T cells recognize an antigen on cancer cells","source":{"url":"https://www.leedsth.nhs.uk/?p=50458","host":"leedsth.nhs.uk","quote":"These new receptors will enable the T-cells to recognise and attach to the antigen on the cancer cell.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"}},{"id":"autologous-bcma-directed-car","name":"Autologous BCMA-directed CAR T-cell therapy","how_it_works":{"text":"Engineered cells are designed to recognize BCMA, a protein on myeloma cells","source":{"url":"https://www.cancer.gov/news-events/cancer-currents-blog/2021/fda-ide-cel-car-t-multiple-myeloma","host":"cancer.gov","quote":"genetic engineering lets the CAR T cells \"see\" BCMA, a protein that's present at high amounts in multiple myeloma cells","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"}}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1}}},"hrefLanguages":[{"rel":"alternate","hreflang":"ru","language":"ru","href":"https://ru.bookimed.com/clinics/country=germany/procedure=car-t-kletocnaa-terapia/"}],"questionsAndAnswers":[{"id":"63c94a2455d8d542d7ece192","question":"L’Allemagne est-elle un pays approprié pour la thérapie cellulaire CAR T ?","answer":"<p>Selon Bookimed, l&#39;Allemagne est l&#39;une des meilleures destinations pour la thérapie cellulaire CAR T grâce à ses technologies médicales avancées, ses équipements modernes et ses médecins hautement qualifiés. Voici quelques raisons:</p><ul><li> L&#39;Allemagne a un taux de réussite élevé et une bonne réputation dans le domaine de la thérapie cellulaire CAR-T, qui attire des touristes médicaux du monde entier.</li><li> Helios Berlin-Buch, une clinique proposant la thérapie cellulaire CAR T, a été classée parmi les meilleurs centres d&#39;Allemagne par le magazine Focus en 2018, avec 94 % des patients le recommandant pour le diagnostic et le traitement.</li><li> L&#39;hôpital est spécialisé dans l&#39;oncologie et l&#39;oncologie chirurgicale, l&#39;orthopédie, la neurochirurgie et le traitement de l&#39;obésité.</li><li> Des patients de différents pays, dont la Russie, sont traités en Allemagne et Bookimed propose des services de coordination médicale pour aider les patients à trouver les meilleures cliniques et médecins pour leurs besoins spécifiques.</li><li> Les cliniques allemandes disposent de chambres confortables, d&#39;une nourriture de haute qualité et d&#39;un personnel professionnel qui, selon les avis des patients, prodiguent d&#39;excellents soins.</li><li> Les patients apprécient la transparence des prix et le fait que le coût du traitement est souvent inférieur lorsqu&#39;ils commandent via Bookimed.</li></ul>","is_active":true,"created_at":"2023-01-25T16:05:45.095+00:00","category":{"id":"63c9416055d8d542d7ecdf1a","name":"top_questions","title":"top_questions"},"relations":[{"key":"operation","value":"car-t-cell-therapy"},{"key":"country","value":"germany"}]},{"id":"644140d23d22aa9d23ad8e4e","question":"Combien de temps faut-il pour recevoir une thérapie cellulaire CAR T en Allemagne ?","answer":"Voyager en Allemagne pour un traitement par cellules CAR T peut prendre jusqu&#39;à plusieurs semaines, y compris l&#39;examen médical, le traitement, la récupération et les visites de suivi, en fonction de votre cas individuel et de votre plan de traitement.","is_active":true,"created_at":"2023-04-01T00:00:00.000+00:00","category":{"id":"63c9416055d8d542d7ecdf1a","name":"top_questions","title":"top_questions"},"relations":[{"key":"operation","value":"car-t-cell-therapy"},{"key":"country","value":"germany"}]},{"id":"6441413f3d22aa9d23ad9108","question":"Quel hôpital est le meilleur pour la thérapie cellulaire CAR T en Allemagne ?","answer":"<p>Le classement Bookimed a révélé les 5 meilleures cliniques allemandes pour la thérapie cellulaire CAR-T :</p><ol><li> <strong>Clinique Nordwest (Krankenhaus)</strong><br></li><li> <strong>Hôpital Asklepios de Barmbek</strong><br></li><li> <strong>Association des cliniques de Düsseldorf</strong><br></li><li> <strong>Clinique Asklepios Saint-Georges</strong><br></li><li> <strong>Hôpital Hélios de Krefeld</strong><br></li></ol>","is_active":true,"created_at":"2023-04-01T00:00:00.000+00:00","category":{"id":"63c9416055d8d542d7ecdf1a","name":"top_questions","title":"top_questions"},"relations":[{"key":"operation","value":"car-t-cell-therapy"},{"key":"country","value":"germany"}]},{"id":"6441b3613d22aa9d23ad9632","question":"Qui est le meilleur médecin en thérapie cellulaire CAR T en Allemagne ?","answer":"<p>Bookimed a identifié les meilleurs médecins d&#39;Allemagne qui ont réussi à mener une thérapie cellulaire CAR-T :</p><ol><li> <strong>Axel Stang</strong> , hématologue, oncologie, 27 ans d&#39;expérience</li><li> <strong>Boris Pfaffenbach</strong> , oncohématologue, 31 ans d&#39;expérience</li><li> <strong>Carl J. Oldhafer</strong> , hématologie, oncologie</li><li> <strong>Elke Jäger</strong> , hématologue, oncologie, 38 ans d&#39;expérience</li><li> <strong>Bertram Glass</strong> , hématologue, oncologie, 29 ans d&#39;expérience</li></ol>","is_active":true,"created_at":"2023-04-01T00:00:00.000+00:00","category":{"id":"63c9416055d8d542d7ecdf1a","name":"top_questions","title":"top_questions"},"relations":[{"key":"operation","value":"car-t-cell-therapy"},{"key":"country","value":"germany"}]},{"id":"6a2201c6b19f4d6cec0526d4","question":"Qu'est-ce que la thérapie par cellules CAR-T et pour quels cancers est-elle approuvée en Allemagne ?","answer":"<p>La thérapie par cellules CAR-T est une immunothérapie personnalisée où les médecins modifient génétiquement les propres cellules T d'un patient pour identifier et détruire le cancer. En Allemagne, cette thérapie est approuvée pour certains cancers du sang, notamment la leucémie, divers lymphomes et le myélome multiple lorsque les traitements standards ont échoué.</p> <ul> <li><strong>Leucémie approuvée :</strong> Traite la leucémie aiguë lymphoblastique (LAL) à cellules B chez les enfants et les jeunes adultes.</li> <li><strong>Indications pour les lymphomes :</strong> Approuvée pour les types de lymphomes diffus à grandes cellules B, à cellules du manteau et folliculaires.</li> <li><strong>Traitement du myélome :</strong> Utilisé pour le myélome multiple lorsque les plasmocytes deviennent cancéreux et résistent à la chimiothérapie.</li> <li><strong>Surveillance médicale :</strong> Administrée dans des centres spécialisés comme la clinique Nordwest à Francfort-sur-le-Main.</li> </ul> <p><strong>Avis d'expert Bookimed :</strong> L'Allemagne offre un avantage financier significatif pour ce traitement avancé. Alors que la procédure coûte en moyenne _price_compare_US_average_ aux États-Unis, les patients en Allemagne peuvent accéder aux mêmes protocoles pour _op_800_price_from_ à _op_800_price_to_. Cela représente une économie d'environ _price_percent_discount_% sans compromis sur la technologie innovante ou les normes de sécurité.</p> <p><strong>Consensus des patients :</strong> Beaucoup reconnaissent que le traitement est physiquement intense en raison d'effets secondaires comme une forte fièvre. La période de surveillance après la perfusion est souvent plus difficile pour les familles que la procédure elle-même.</p>","is_active":true,"created_at":"2026-06-04T22:52:54.923+00:00","category":{"id":"68f5f2ea1567cb687e0a7542","name":"faq_content","title":"faq_content"},"relations":[{"key":"country","value":"germany"},{"key":"operation","value":"car-t-cell-therapy"}]},{"id":"6a220219b23ce9d2b50dd535","question":"Quels hôpitaux en Allemagne sont certifiés pour administrer la thérapie par cellules CAR-T ?","answer":"<p>Les hôpitaux certifiés en Allemagne pour la thérapie par cellules CAR-T comprennent l'hôpital universitaire de Heidelberg, l'hôpital universitaire de Francfort et la clinique Nordwest de Francfort. Ces centres universitaires détiennent des certifications spécialisées pour le traitement des cancers du sang agressifs. Beaucoup proposent une logistique liée au fabricant, des capacités d'aphérèse et des unités de surveillance intensive essentielles à l'administration sûre de l'immunothérapie cellulaire.</p> <ul> <li><strong>Université de Heidelberg :</strong> Premier centre allemand certifié pour la thérapie par cellules CAR-T avec des capacités de production cellulaire en interne.</li> <li><strong>Clinique Nordwest de Francfort :</strong> Centre d'oncologie certifié par l'ESMO comprenant cinq instituts de recherche et des centres spécialisés dans le développement du cancer.</li> <li><strong>Hôpital universitaire de Cologne :</strong> Établissement certifié de premier plan, expert dans la coordination des parcours de l'aphérèse à la perfusion pour les patients atteints de lymphome.</li> <li><strong>Wurtzbourg et Ulm :</strong> Hôpitaux universitaires reconnus fournissant un soutien en soins intensifs pour la surveillance des immunothérapies complexes.</li> </ul> <p><strong>Avis d'expert Bookimed :</strong> L'Allemagne est un leader mondial, se classant 3e dans notre réseau pour les demandes en oncologie. Seule une petite fraction de ses 82 cliniques peut proposer la thérapie par cellules CAR-T. La clinique Nordwest se distingue. Elle traite 61 000 patients par an et détient l'honneur des \"World's Best Hospitals 2021\". Ce volume garantit des normes de sécurité élevées pour les thérapies cellulaires complexes.</p> <p><strong>Consensus des patients :</strong> Trouver un hôpital certifié n'est que la première étape. Les patients soulignent que faire coordonner l'orientation par un hématologue est l'étape cruciale pour obtenir une place de traitement.</p>","is_active":true,"created_at":"2026-06-04T22:54:17.006+00:00","category":{"id":"68f5f2ea1567cb687e0a7542","name":"faq_content","title":"faq_content"},"relations":[{"key":"country","value":"germany"},{"key":"operation","value":"car-t-cell-therapy"}]},{"id":"6a2202627be7d3f7f20d6bd2","question":"Quels sont les principaux effets secondaires précoces et tardifs après une perfusion de cellules CAR-T ?","answer":"<p>Les effets secondaires de la thérapie par cellules CAR-T en Allemagne surviennent en deux étapes distinctes. Les effets de la phase précoce incluent le syndrome de libération de cytokines et le syndrome de neurotoxicité associé aux cellules effectrices immunitaires dans les 28 jours. Les effets de la phase tardive impliquent des cytopénies prolongées, une aplasie des cellules B et une immunosuppression persistante survenant des mois après la perfusion.</p> <ul> <li><strong>Syndrome de libération de cytokines :</strong> Inflammation systémique provoquant une forte fièvre, une hypotension et une hypoxie dans les 48 heures.</li> <li><strong>Neurotoxicité (ICANS) :</strong> Symptômes neurologiques tels que confusion, encéphalopathie, faiblesse motrice et convulsions peu après la perfusion.</li> <li><strong>Cytopénies prolongées :</strong> Faibles taux persistants de globules blancs et de plaquettes au-delà d'un mois.</li> <li><strong>Aplasie des cellules B :</strong> Épuisement des cellules B saines entraînant de faibles niveaux d'anticorps et des risques d'infection.</li> </ul> <p><strong>Avis d'expert Bookimed :</strong> Les centres allemands comme la clinique Nordwest utilisent une surveillance intensive car les effets secondaires apparaissent souvent après que les patients se sentent bien. Bien que le syndrome de libération de cytokines soit bien connu, la neurotoxicité peut être subtile, commençant par de simples problèmes de recherche de mots ou des tremblements. Les principaux hôpitaux allemands intègrent des équipes de neurologie spécialisées dans les unités d'oncologie pour gérer ces transitions spécifiques en toute sécurité.</p> <p><strong>Consensus des patients :</strong> De nombreux patients trouvent que la fatigue profonde et le `brouillard mental` sont plus persistants que ce que suggèrent les descriptions cliniques. Les aidants doivent surveiller tout changement subtil dans l'élocution ou la vigilance pendant les premières semaines à la maison.</p>","is_active":true,"created_at":"2026-06-04T22:55:30.140+00:00","category":{"id":"68f5f2ea1567cb687e0a7542","name":"faq_content","title":"faq_content"},"relations":[{"key":"country","value":"germany"},{"key":"operation","value":"car-t-cell-therapy"}]},{"id":"6a2202a872f9a2a33c0cc222","question":"Comment la phase de récupération est-elle gérée pour limiter les complications liées aux infections ?","answer":"<p>La récupération implique une surveillance intensive au sein de centres d'oncologie allemands spécialisés pour prévenir les infections pendant la phase de neutropénie. Les cliniciens utilisent des médicaments prophylactiques, un isolement protecteur strict et des analyses de sang fréquentes pour gérer l'immunité. Des établissements avancés comme la clinique Nordwest utilisent la recherche intégrée pour identifier et traiter précocement les complications telles que le syndrome de libération des cytokines.</p> <ul> <li><strong>Médication prophylactique :</strong> Les patients reçoivent des antibiotiques, des antiviraux et des antifongiques obligatoires pendant les périodes de vulnérabilité.</li> <li><strong>Isolement strict :</strong> Les patients doivent éviter les foules, les transports publics et les contacts avec des personnes malades après la perfusion.</li> <li><strong>Surveillance des infections :</strong> Une hospitalisation immédiate et des antibiotiques par voie intraveineuse sont requis en cas de fièvre post-traitement.</li> <li><strong>Soutien immunitaire :</strong> Les médecins peuvent administrer des immunoglobulines par voie intraveineuse si les taux d'anticorps restent dangereusement bas.</li> </ul> <p><strong>Avis d'expert Bookimed :</strong> Les cliniques allemandes comme la clinique Nordwest font le pont entre la recherche et les soins en hébergeant des instituts spécialisés sur place. Cette intégration signifie que les patients bénéficient d'une surveillance en temps réel de la reconstitution immunitaire, ce qui dicte exactement quand les précautions de sécurité peuvent être assouplies. Cette approche basée sur les données garantit que la sécurité ne repose pas uniquement sur les symptômes, mais sur une récupération cellulaire vérifiée.</p> <p><strong>Consensus des patients :</strong> De nombreux patients soulignent la nécessité d'une vigilance constante, notamment des prises de température fréquentes et le port strict du masque. Ils recommandent de garder un thermomètre à portée de main en tout temps et de savoir exactement quels symptômes nécessitent un retour urgent à l'hôpital.</p>","is_active":true,"created_at":"2026-06-04T22:56:40.972+00:00","category":{"id":"68f5f2ea1567cb687e0a7542","name":"faq_content","title":"faq_content"},"relations":[{"key":"country","value":"germany"},{"key":"operation","value":"car-t-cell-therapy"}]},{"id":"6a2202ece3595724fa05b4c2","question":"Comment un patient peut-il accéder aux cliniques de thérapie par cellules CAR-T en Allemagne et réserver une consultation ?","answer":"<p>Les patients accèdent à la thérapie par cellules CAR-T en Allemagne via un processus d'admission basé sur une recommandation dans des centres universitaires spécialisés. La plupart des cas nécessitent un examen initial par un hématologue ou un oncologue pour vérifier l'éligibilité en fonction des antécédents de traitement et des sous-types spécifiques de cancer du sang avant de réserver une consultation spécialisée.</p> <ul> <li><strong>Exigence de recommandation :</strong> Les oncologues locaux doivent orienter les patients vers des hôpitaux universitaires pour une thérapie cellulaire avancée.</li> <li><strong>Centres cliniques :</strong> Le traitement a lieu dans des établissements d'élite comme la clinique Nordwest ou de grands hôpitaux universitaires.</li> <li><strong>Documentation :</strong> Les centres exigent des rapports complets de pathologie, d'imagerie et des calendriers de traitement pour le premier examen.</li> <li><strong>Autorisation d'assurance :</strong> Les équipes hospitalières aident à l'obtention de l'autorisation en raison de la grande complexité et des réglementations de la thérapie.</li> <li><strong>Admission spécialisée :</strong> La réservation est un examen de cas en plusieurs étapes plutôt qu'un rendez-vous ambulatoire standard.</li> </ul> <p><strong>Avis de l'expert Bookimed :</strong> L'Allemagne se classe parmi les 3 premières destinations mondiales pour l'hématologie complexe en raison de sa structure hospitalière universitaire centralisée. Bien qu'il existe des cliniques plus petites, nos données montrent que les patients obtiennent de meilleurs résultats dans des établissements axés sur la recherche comme la clinique Nordwest. Ces centres utilisent des équipes spécialisées pour gérer la transition de plusieurs semaines entre la recommandation initiale et la phase de collecte des cellules par leucaphérèse.</p> <p><strong>Consensus des patients :</strong> L'accès à ces centres est mieux géré en préparant un dossier médical exhaustif pour éviter les retards. De nombreux patients soulignent que le fait d'avoir un oncologue qui soutient la recommandation accélère le processus de sélection de l'éligibilité.</p>","is_active":true,"created_at":"2026-06-04T22:57:48.674+00:00","category":{"id":"68f5f2ea1567cb687e0a7542","name":"faq_content","title":"faq_content"},"relations":[{"key":"country","value":"germany"},{"key":"operation","value":"car-t-cell-therapy"}]}],"seoTests":{"thin_content":false,"no_txt_after_3_clinics":false},"offerFilters":{"offer_count":0,"country_filter":[{"id":46,"name":"Turquie","alias":"turkey","iso_code":"TR"},{"id":1,"name":"Israël","alias":"israel","iso_code":"IL"},{"id":203,"name":"Chine","alias":"china","iso_code":"CN"}],"price_filter":{"from":0,"to":0,"avg":0}},"leadsCount":{"leads_count":31},"manualSeo":[],"updatedAt":"2026-11-01T20:23:30.987Z","activeCountries":["TR","ES","DE","TH"],"hasVideoReviewsByContext":false,"hasCriticalApiFallback":false}